PD-L1 Upregulation Drives Escape from Anti-CTLA4 and Radiation Therapy.
出版信息
Cancer Discov. 2015 May;5(5):OF13. doi: 10.1158/2159-8290.CD-RW2015-049. Epub 2015 Mar 19.
Abstract
摘要
相似文献
1
PD-L1 Upregulation Drives Escape from Anti-CTLA4 and Radiation Therapy.程序性死亡配体1（PD-L1）上调促使肿瘤细胞逃避抗细胞毒性T淋巴细胞相关蛋白4（CTLA4）和放射治疗。
Cancer Discov. 2015 May;5(5):OF13. doi: 10.1158/2159-8290.CD-RW2015-049. Epub 2015 Mar 19.
2
Radiation and dual checkpoint blockade activate non-redundant immune mechanisms in cancer.放疗和双重检查点阻断激活癌症中的非冗余免疫机制。
Nature. 2015 Apr 16;520(7547):373-7. doi: 10.1038/nature14292. Epub 2015 Mar 9.
3
Radiotherapy complements immune checkpoint blockade.放疗与免疫检查点抑制剂相辅相成。
Cancer Cell. 2015 Apr 13;27(4):437-8. doi: 10.1016/j.ccell.2015.03.015.
4
Immunotherapy: A triple blow for cancer.免疫疗法：癌症的三重打击。
Nat Rev Cancer. 2015 May;15(5):258-9. doi: 10.1038/nrc3946. Epub 2015 Apr 2.
5
Tumour immunology: A triple blow for cancer.肿瘤免疫学：癌症的三重打击。
Nat Rev Immunol. 2015 May;15(5):265. doi: 10.1038/nri3844. Epub 2015 Mar 27.
6
Immunotherapy: Combined immunoradiotherapy reinvigorates antitumour immunity.免疫疗法：联合免疫放射疗法可重振抗肿瘤免疫力。
Nat Rev Clin Oncol. 2015 Jun;12(6):311. doi: 10.1038/nrclinonc.2015.54. Epub 2015 Mar 24.
7
Radiotherapy and immune checkpoint blockade: potential interactions and future directions.放疗与免疫检查点阻断：潜在的相互作用和未来方向。
Trends Mol Med. 2015 Aug;21(8):463-5. doi: 10.1016/j.molmed.2015.05.007. Epub 2015 Jun 16.
8
The benefits of immunotherapy combinations.免疫疗法联合治疗的益处。
Nature. 2017 Dec 21;552(7685):S67-S69. doi: 10.1038/d41586-017-08702-7.
9
Immunotherapy and Checkpoint Inhibitors in Recurrent and Metastatic Head and Neck Cancer.复发性和转移性头颈癌的免疫疗法与检查点抑制剂
Am Soc Clin Oncol Educ Book. 2016;35:e277-82. doi: 10.14694/EDBK_157801.
10
Combining forces: the promise and peril of synergistic immune checkpoint blockade and targeted therapy in metastatic melanoma.联合力量：转移性黑色素瘤中协同性免疫检查点阻断与靶向治疗的前景与风险
Cancer Metastasis Rev. 2017 Mar;36(1):43-50. doi: 10.1007/s10555-017-9656-2.
Zotero 插件